Home Coronavirus COVID-19 Johnson & Johnson Covid-19 Vaccine: 66% Effective in Global Trial, but 85%... Johnson & Johnson Covid-19 Vaccine: 66% Effective in Global Trial, but 85% Against Severe Disease January 29, 2021 You are unauthorized to view this page. Username or E-mail Password Remember Me Forgot Password RELATED ARTICLESMORE FROM AUTHOR Trump’s Tariffs on Canada, Mexico, and China Take Effect Bird Flu in US Pushes Poultry Prices in Mexico to 4-Year High Trump to Impose Tariffs on Mexico and Canada Aurora Phelps, Alleged Scammer and Kidnapper, Had Victims in Chapala In Historic First, Mexico Mass-Extradites Dozens of Cartel Operatives to the US
